| UniProt ID | PI2R_HUMAN | |
|---|---|---|
| UniProt AC | P43119 | |
| Protein Name | Prostacyclin receptor | |
| Gene Name | PTGIR | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 386 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. |
|
| Protein Description | Receptor for prostacyclin (prostaglandin I2 or PGI2). The activity of this receptor is mediated by G(s) proteins which activate adenylate cyclase.. | |
| Protein Sequence | MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATDLLGTSFLSPAVFVAYARNSSLLGLARGGPALCDAFAFAMTFFGLASMLILFAMAVERCLALSHPYLYAQLDGPRCARLALPAIYAFCVLFCALPLLGLGQHQQYCPGSWCFLRMRWAQPGGAAFSLAYAGLVALLVAAIFLCNGSVTLSLCRMYRQQKRHQGSLGPRPRTGEDEVDHLILLALMTVVMAVCSLPLTIRCFTQAVAPDSSSEMGDLLAFRFYAFNPILDPWVFILFRKAVFQRLKLWVCCLCLGPAHGDSQTPLSQLASGRRDPRAPSAPVGKEGSCVPLSAWGEGQVEPLPPTQQSSGSAVGTSSKAEASVACSLC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | N-linked_Glycosylation | -MADSCRNLTYVRGS -CCCCCCCCCEECCC | 40.85 | UniProtKB CARBOHYD | |
| 14 | Phosphorylation | NLTYVRGSVGPATST CCCEECCCCCCCHHH | 17.21 | - | |
| 19 | Phosphorylation | RGSVGPATSTLMFVA CCCCCCCHHHHHHHC | 25.94 | - | |
| 20 | Phosphorylation | GSVGPATSTLMFVAG CCCCCCHHHHHHHCC | 22.96 | - | |
| 39 | Phosphorylation | GLALGILSARRPARP CHHHHHHHCCCCCCH | 20.15 | 24719451 | |
| 78 | N-linked_Glycosylation | VFVAYARNSSLLGLA HHHHHHCCCHHHHHH | 27.98 | 17660510 | |
| 245 | Phosphorylation | LILLALMTVVMAVCS HHHHHHHHHHHHHHC | 15.70 | 30206219 | |
| 252 | Phosphorylation | TVVMAVCSLPLTIRC HHHHHHHCCCHHHHH | 26.82 | 30206219 | |
| 256 | Phosphorylation | AVCSLPLTIRCFTQA HHHCCCHHHHHHHHC | 12.39 | 30206219 | |
| 308 | S-palmitoylation | QRLKLWVCCLCLGPA HHHHHHHHHHHHCCC | 0.71 | 12488443 | |
| 311 | S-palmitoylation | KLWVCCLCLGPAHGD HHHHHHHHHCCCCCC | 2.29 | 12488443 | |
| 328 | Phosphorylation | TPLSQLASGRRDPRA CCHHHHHCCCCCCCC | 41.23 | 22817900 | |
| 337 | Phosphorylation | RRDPRAPSAPVGKEG CCCCCCCCCCCCCCC | 44.19 | 22798277 | |
| 363 | Phosphorylation | QVEPLPPTQQSSGSA CCCCCCCCCCCCCCC | 36.98 | 28270605 | |
| 366 | Phosphorylation | PLPPTQQSSGSAVGT CCCCCCCCCCCCCCC | 27.18 | 28270605 | |
| 367 | Phosphorylation | LPPTQQSSGSAVGTS CCCCCCCCCCCCCCC | 32.22 | 28270605 | |
| 369 | Phosphorylation | PTQQSSGSAVGTSSK CCCCCCCCCCCCCCH | 23.02 | 28270605 | |
| 373 | Phosphorylation | SSGSAVGTSSKAEAS CCCCCCCCCCHHHHH | 24.19 | 28270605 | |
| 374 | Phosphorylation | SGSAVGTSSKAEASV CCCCCCCCCHHHHHH | 24.74 | 28270605 | |
| 375 | Phosphorylation | GSAVGTSSKAEASVA CCCCCCCCHHHHHHH | 35.40 | 28270605 | |
| 383 | Farnesylation | KAEASVACSLC---- HHHHHHHHCCC---- | 2.75 | 11895442 | |
| 383 | Methylation | KAEASVACSLC---- HHHHHHHHCCC---- | 2.75 | - | |
| 383 | Farnesylation | KAEASVACSLC---- HHHHHHHHCCC---- | 2.75 | 11895442 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PI2R_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D00106 | Epoprostenol (USAN/INN); Prostaglandin I2; Prostacyclin; Epoprostenol (TN) | |||||
| D01188 | Pimilprost (JAN/INN) | |||||
| D01337 | Epoprostenol sodium (JAN/USAN); Flolan (TN) | |||||
| D01385 | Ibudilast (JP16/INN); Ketas (TN) | |||||
| D01551 | Beraprost sodium (JP16/USAN); Procylin (TN) | |||||
| D02048 | Clinprost (JAN/INN); TEI 9090; Arteron (TN) | |||||
| D02720 | Beraprost (USAN) | |||||
| D02721 | Iloprost (USAN/INN); Ventavis (TN) | |||||
| D06213 | Treprostinil (JAN/USAN/INN); Remodulin (TN) | |||||
| D08065 | Iloprost tromethamine; Ventavis (TN) | |||||
| D08628 | Treprostinil monosodium salt; Treprostinil sodium; Remodulin (TN) | |||||
| D09994 | Selexipag (JAN/USAN/INN) | |||||
| D10430 | Treprostinil diolamine (USAN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Palmitoylation | |
| Reference | PubMed |
| "Palmitoylation of the human prostacyclin receptor. Functionalimplications of palmitoylation and isoprenylation."; Miggin S.M., Lawler O.A., Kinsella B.T.; J. Biol. Chem. 278:6947-6958(2003). Cited for: PALMITOYLATION AT CYS-308 AND CYS-311, LACK OF PALMITOYLATION ATCYS-309, AND MUTAGENESIS OF CYS-308; CYS-309 AND CYS-311. | |
| Prenylation | |
| Reference | PubMed |
| "Investigation of a functional requirement for isoprenylation by thehuman prostacyclin receptor."; Miggin S.M., Lawler O.A., Kinsella B.T.; Eur. J. Biochem. 269:1714-1725(2002). Cited for: ISOPRENYLATION AT CYS-383, AND MUTAGENESIS OF CYS-383. | |